Loading
UI
Universal Ibogaine Inc. Stock: price and insider trades · Canada
Universal Ibogaine Inc.: what insiders have been doing
Insider filings for Universal Ibogaine Inc. are scarce in the SEDI feed, the latest one published on 19 September 2025. This page will fill in as new trades are disclosed. Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
7
Thresholds
n/a
Buy Volume
€853
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJames Andrew Duncan1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 19 September 2025
Declarations7 total
Restricted Share UnitsTSXSEDI:4577463
6,000,000 sharesRestricted Share UnitsTSXSEDI:4577466
Common SharesTSXSEDI:4573962
Common SharesTSXSEDI:4573960
4,248,000 shares@ CA$0.025100.0% of flowCommon SharesTSXSEDI:4546059
67,000 shares@ CA$0.02100.0% of flowCommon SharesTSXSEDI:4530993
Canonical exit: 15 Sept 2025 (T+90)
Common SharesTSXSEDI:4529196
7 of 7 declarations
About Universal Ibogaine Inc.
Universal Ibogaine Inc. is a company focused on developing ibogaine-based treatments for addiction. It is listed on the Toronto Stock Exchange under the symbol XTSE.
